2017
DOI: 10.1097/md.0000000000004662
|View full text |Cite
|
Sign up to set email alerts
|

Analysis of volumetric response of pituitary adenomas receiving adjuvant CyberKnife stereotactic radiosurgery with the application of an exponential fitting model

Abstract: Tumor control rates of pituitary adenomas (PAs) receiving adjuvant CyberKnife stereotactic radiosurgery (CK SRS) are high. However, there is currently no uniform way to estimate the time course of the disease. The aim of this study was to analyze the volumetric responses of PAs after CK SRS and investigate the application of an exponential decay model in calculating an accurate time course and estimation of the eventual outcome.A retrospective review of 34 patients with PAs who received adjuvant CK SRS between… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
5
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
5
1
1

Relationship

0
7

Authors

Journals

citations
Cited by 8 publications
(5 citation statements)
references
References 44 publications
0
5
0
Order By: Relevance
“…Accurately and efficiently measuring tumor burden and tumor response to therapy remains challenging in oncology, with limitations in response evaluation criteria in solid tumors being well described. [22][23][24] This study utilized automated software that removes variability in choosing the axial slice at which to assess the longest diameter and 19,21,40 Interobserver variability is well documented with response evaluation criteria in solid tumors categorization. 22,23,30 This was also found in this study, where agreement categorization varied from poor to mod- head and neck tumors for radiation therapy planning, but also acknowledge the need to review any automatically generated contours prior to planning.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Accurately and efficiently measuring tumor burden and tumor response to therapy remains challenging in oncology, with limitations in response evaluation criteria in solid tumors being well described. [22][23][24] This study utilized automated software that removes variability in choosing the axial slice at which to assess the longest diameter and 19,21,40 Interobserver variability is well documented with response evaluation criteria in solid tumors categorization. 22,23,30 This was also found in this study, where agreement categorization varied from poor to mod- head and neck tumors for radiation therapy planning, but also acknowledge the need to review any automatically generated contours prior to planning.…”
Section: Discussionmentioning
confidence: 99%
“…15,16 Evaluation of solid tumor response to therapy is currently commonly conducted using the simplified response evaluation criteria in solid tumors guidelines, although other criteria may be defined as investigators search for improved methods. [17][18][19][20][21] The is high interobserver and intraobserver variability due to challenges associated with determining lesion borders and in the perception of the longest diameter. [22][23][24] These recognized limitations have led to approaches that fully or semi-automate lesion segmentation (ie, contouring tumor margins) for response evaluation criteria in solid tumors or volume assessment in order to reduce subjectivity and improve reliability and reproducibility, given that response assessment impacts clinical decision-making.…”
mentioning
confidence: 99%
“…Kinetic visual field (VF) is very useful at advanced stages of the disease and in patients who have difficulties in performing a static VF. Although Octopus static perimetry test is helpful in the diagnosis of pituitary tumours, it may not reveal early optic nerve damage [10] and it should be noted that prolonged compression to the optic chiasm may produce deep and irreversible visual field defects [11].…”
Section: Resultsmentioning
confidence: 99%
“…Interestingly, an early transient increase of the tumour volume post RT (> 15%) has been shown in 62.5% of 34 patients treated with CK (93% having NFPA), mainly in the first 4 months. Fortunately, this was not predictive of the eventual tumour regression or progression (54). The median time for a tumour that initially progressed to tumour volume stability was 9.2 months (54).…”
Section: Nonfunctioning Pituitary Adenomasmentioning
confidence: 96%
“…Fortunately, this was not predictive of the eventual tumour regression or progression (54). The median time for a tumour that initially progressed to tumour volume stability was 9.2 months (54). Transient swelling has also been reported in 9% of 45 patients with NFPA treated with GK (55).…”
Section: Nonfunctioning Pituitary Adenomasmentioning
confidence: 99%